Martin Hahn

Martin Hahn is an experienced professional in the biotechnology and protein technology sectors, currently serving as the Head of Global Emerging Platforms and Technologies at GELITA since May 2016, focusing on innovative collagen production methods. Previously, Martin held various roles at GELITA, including responsibilities for global product development and technical management of collagen peptides. Prior to GELITA, Martin led protein technology development at Siemens Healthcare Diagnostics Products GmbH from 2006 to 2016 and managed research projects at Philipps-Universität Marburg between 2005 and 2006. Academic credentials include a Master of Business Administration from ESMT Berlin, a Dr. rer. nat in Biochemistry and Molecular Biology, and a Diplom in Chemistry from The Philipp University of Marburg, alongside studies at ETH Zürich and Karlsruhe Institute of Technology.